EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metropolitan/nonmetropolitan differences of the impact of COVID‐19 on cancer survivors' care

Whitney E Zahnd, Jason T Semprini, Robin C Vanderpool, Sarah H Nash, Erin L Van Blarigan, Mindy C DeRouen, Angela L W Meisner, Chuck Wiggins

The Journal of Rural Health · 2025

DOI: 10.1111/jrh.70061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Rural Health, 2025. Verfasst von Whitney E Zahnd und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Management and Policy, College of Public Health, University of Iowa, Iowa City, Iowa, USA. Hauptthemen laut MEDLINE: COVID-19, Cancer Survivors, Neoplasms, Urban Population. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: New Mexico Tumor Registry, California Department of Public Health, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate pandemic‐related changes in cancer‐related care for cancer survivors residing in nonmetropolitan and metropolitan areas.

Methods

We used data from the Health Information National Trends‐Surveillance Epidemiology End Results (HINTS‐SEER) survey administered to cancer survivors from the Greater San Francisco Bay Area, Iowa, and New Mexico between January and August 2021. Respondents were queried on changes to their cancer‐related care, including treatment, follow‐up appointments, and routine cancer screening/preventive care. We calculated weighted percentages and Rao‐Scott chi‐square tests for reported differences between nonmetropolitan and metropolitan areas.

Findings

Compared to survivors residing in metropolitan areas, a higher proportion of those in nonmetropolitan areas reported that their cancer treatment or follow‐up appointments were unaffected by the pandemic (38.6% vs 28.1%; P = .008). Survivors in metropolitan areas experienced more of a shift in cancer treatment or follow‐up appointments to telehealth (12.5% vs 5.7%, P = .003), but there was no difference in appointment cancellations. More survivors residing in metropolitan versus nonmetropolitan areas reported shifts to telehealth for preventive care (8.2% vs 2.9%, P = .005). There was no difference across nonmetropolitan and metropolitan survivors reporting that cancer‐related care was cancelled, that routine cancer screening or preventive care was unaffected by the pandemic, or that providers discussed COVID‐19 risks.

Conclusions

Survivors in nonmetropolitan compared to metropolitan areas had less perceived change in cancer follow‐up and treatment schedules. It will be important to assess whether shifts in follow‐up and preventive care to telehealth for cancer survivors in need of care during the COVID‐19 pandemic affect their long‐term outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Cancer SurvivorsNeoplasmsUrban PopulationRural PopulationHumansMaleFemaleMiddle AgedAgedAdultSan FranciscoIowaNew MexicoTelemedicineSARS-CoV-2SEER ProgramUnited States

Stichwörter der Autor:innen

COVID‐19 pandemiccancercancer survivorshippreventive carerural healthtelehealth

Autor:innen und Institutionen

  • Department of Health Management and Policy, College of Public Health, University of Iowa, Iowa City, Iowa, USA.
  • Department of Public Health, College of Health Sciences, Des Moines University, West Des Moines, Iowa, USA.
  • Health Communication and Informatics Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland, USA.
  • Department of Epidemiology and Iowa Cancer Registry, College of Public Health, University of Iowa, Iowa City, Iowa, USA.
  • Department of Epidemiology and Biostatistics, University of California San Francisco, San Franscico, California, USA.
  • Greater Bay Area Cancer Registry, San Francisco, California, USA.

Förderung

  • New Mexico Tumor Registry
  • California Department of Public Health
  • NCI NIH HHS
  • Greater Bay Area Cancer Registry
  • Iowa Cancer Registry
  • National Cancer Institute

Zitieren

APA

Zahnd, W. E., Semprini, J. T., Vanderpool, R. C., Nash, S. H., Van Blarigan, E. L., DeRouen, M. C., Meisner, A. L. W., & Wiggins, C. (2025). Metropolitan/nonmetropolitan differences of the impact of COVID‐19 on cancer survivors' care. The Journal of Rural Health. https://doi.org/10.1111/jrh.70061

Vancouver

Zahnd WE, Semprini JT, Vanderpool RC, Nash SH, Van Blarigan EL, DeRouen MC, et al. Metropolitan/nonmetropolitan differences of the impact of COVID‐19 on cancer survivors' care. The Journal of Rural Health. 2025. doi:10.1111/jrh.70061

BibTeX
@article{Zahnd2025,
  author = {Zahnd, Whitney E and Semprini, Jason T and Vanderpool, Robin C and Nash, Sarah H and Van Blarigan, Erin L and DeRouen, Mindy C and Meisner, Angela L W and Wiggins, Chuck},
  title = {Metropolitan/nonmetropolitan differences of the impact of COVID‐19 on cancer survivors' care},
  journal = {The Journal of Rural Health},
  year = {2025},
  doi = {10.1111/jrh.70061}
}
Kostenlos starten →